VTR
43
-3
VRSK
63
-3
ORCL
52
-7
MHK
31
-3
JNJ
36
3
XEL
53
-2
CHRW
51
-6
TROW
50
2
ISRG
68
-3
ADP
59
-2
MRK
33
3
EQR
40
-4
PBI
59
-7
SWKS
53
3
GOOG
81
-2
NWS
52
-4
AIZ
66
-2
ALL
41
6
FSLR
63
5
PHM
53
-4
VTR
43
-3
VRSK
63
-3
ORCL
52
-7
MHK
31
-3
JNJ
36
3
XEL
53
-2
CHRW
51
-6
TROW
50
2
ISRG
68
-3
ADP
59
-2
MRK
33
3
EQR
40
-4
PBI
59
-7
SWKS
53
3
GOOG
81
-2
NWS
52
-4
AIZ
66
-2
ALL
41
6
FSLR
63
5
PHM
53
-4
Financhill
Back

Kuros Biosciences 10K Form

Buy
52

CSBTF
Kuros Biosciences

Last Price:
22.57
Seasonality Move:
0.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CSBTF News And Ratings

See the #1 stock for the next 7 days that we like better than CSBTF

CSBTF Financial Statistics

Sales & Book Value

Annual Sales: $37.38M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.81
Price / Book: 12.44

Profitability

EPS (TTM): -0.28190
Net Income (TTM): $-10.02M
Gross Margin: $26.66M
Return on Equity: -14.62%
Return on Assets: -11.65%

Kuros Biosciences Earnings Forecast

Key Kuros Biosciences Financial Ratios

  • The Gross Profit Margin over the past 18 years for CSBTF is 71.31%.
  • The Selling, General & Administrative Expenses for CSBTF have been equal to 61.65% of Gross Profit Margin.
  • The Research & Development expenses have been 16.68% of Revenue.
  • The Interest Expense is -1.35% of Operating Income.
  • The Net Earning history of CSBTF is -40.90% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 12 years.

Kuros Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: CSBTF
Website: kurosbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.73
Quick Ratio: 2.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CSBTF Technical Analysis vs Fundamental Analysis

Buy
52
Kuros Biosciences (CSBTF) is a Buy

Is Kuros Biosciences a Buy or a Sell?